Meeting of the Advisory Commission on Childhood Vaccines, 36805 [2017-16582]

Download as PDF Federal Register / Vol. 82, No. 150 / Monday, August 7, 2017 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the Advisory Commission on Childhood Vaccines Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with section 10(a)(2) of the Federal Advisory Committee Act, notice is hereby given that a meeting is scheduled for the Advisory Commission on Childhood Vaccines (ACCV). This meeting will be open to the public. Information about the ACCV and the agenda for this meeting can be obtained by accessing the following Web site: http:// www.hrsa.gov/advisorycommittees/ childhoodvaccines/index.html. DATES: The meeting will be held on September 8, 2017, at 10:00 a.m. EDT. ADDRESSES: The address for the meeting is 5600 Fishers Lane, Rockville, MD, Conference Room 5N54. The public can join the meeting by: 1. (In Person) Persons interested in attending the meeting in person are encouraged to submit a written notification to: Annie Herzog, Division of Injury Compensation Programs (DICP), Healthcare Systems Bureau (HSB), HRSA, Rm. 8N146B, 5600 Fishers Lane, Rockville, Maryland 20857 or email: aherzog@hrsa.gov. Since this meeting is held in a federal government building, attendees will need to go through a security check to enter the building and participate in the meeting. This written notification is encouraged so that a list of attendees can be provided to make entry through security quicker. Persons may attend in person without providing written notification, but their entry into the building may be delayed due to security checks and the requirement to be escorted to the meeting by a federal government employee. To request an escort to the meeting after entering the building, call Amber Johnson at (301) 443–0129. 2. (Audio Portion) Call the conference phone number (800) 369–1833 and providing the following information: Leader Name: Dr. Narayan Nair Password: 6706374 3. (Visual Portion) Connect to the ACCV Adobe Connect Pro Meeting using the following URL: https:// hrsa.connectsolutions.com/accv/. Participants should call and connect 15 minutes prior to the meeting to allow mstockstill on DSK30JT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:14 Aug 04, 2017 Jkt 241001 time for the logistics to be set-up. If you have never attended an Adobe Connect meeting, please test your connection using the following URL: https:// hrsa.connectsolutions.com/common/ help/en/support/meeting_test.htm. Get a quick overview of the software at: http://www.adobe.com/go/ connectpro_overview. FOR FURTHER INFORMATION CONTACT: Anyone requesting information regarding the ACCV should contact Annie Herzog, Program Analyst, DICP, HRSA in one of three ways: (1) Send a request to the following address: Annie Herzog, Program Analyst, DICP, HRSA, 5600 Fishers Lane, 8N146B, Rockville, Maryland 20857; (2) call (301) 443– 6593; or (3) send an email to aherzog@ hrsa.gov. The ACCV will meet on Friday, September 8, 2017, beginning at 10:00 a.m. in the 5600 Fishers Lane Building, Rockville, Maryland 20857; however, meeting times and locations could change. For the latest information regarding meeting start time and location, please check the ACCV Web site: http://www.hrsa.gov/advisory committees/childhoodvaccines/ index.html. The ACCV was established by section 2119 of the Public Health Service Act (the Act) (42 U.S.C. 300aa–19), as enacted by Public Law (Pub. L.) 99–660, and as subsequently amended, and advises the Secretary of HHS (the Secretary) on issues related to implementation of the National Vaccine Injury Compensation Program (VICP). Activities of the ACCV also include: Recommending changes to the Vaccine Injury Table on its own initiative or as the result of the filing of a petition; advising the Secretary in implementing section 2127 of the Act regarding the need for childhood vaccination products that result in fewer or no significant adverse reactions; surveying federal, state, and local programs and activities related to gathering information on injuries associated with the administration of childhood vaccines, including the adverse reaction reporting requirements of section 2125(b) of the Act; advising the Secretary on the methods of obtaining, compiling, publishing, and using credible data related to the frequency and severity of adverse reactions associated with childhood vaccines; consulting on the development or revision of Vaccine Information Statements; and recommending to the Director of the National Vaccine Program research related to vaccine SUPPLEMENTARY INFORMATION: PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 36805 injuries which should be conducted to carry out the VICP. The agenda items for the meeting will include, but are not limited to, updates from DICP, Department of Justice, National Vaccine Program Office, Immunization Safety Office (Centers for Disease Control and Prevention), National Institute of Allergy and Infectious Diseases (National Institutes of Health) and Center for Biologics, Evaluation and Research (Food and Drug Administration). A draft agenda and additional meeting materials will be posted on the ACCV Web site (http:// www.hrsa.gov/advisorycommittees/ childhoodvaccines/index.html) prior to the meeting. Agenda items are subject to change as priorities dictate. Members of the public will have the opportunity to provide comments. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to make oral comments or provide written comments to the ACCV should be sent to Annie Herzog using the address and phone number above by September 4, 2017. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Annie Herzog, using the address and phone number above at least 10 days prior to the meeting. Amy McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2017–16582 Filed 8–4–17; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The U.S. Department of Health and Human Services (HHS) announces the next meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 (Committee). The meeting is open to the public and will be held in the Washington, DC metropolitan area. The Committee is working to accomplish its mission to provide independent advice based on current scientific evidence for SUMMARY: E:\FR\FM\07AUN1.SGM 07AUN1

Agencies

[Federal Register Volume 82, Number 150 (Monday, August 7, 2017)]
[Notices]
[Page 36805]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-16582]



[[Page 36805]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Commission on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act, notice is hereby given that a meeting is scheduled for 
the Advisory Commission on Childhood Vaccines (ACCV). This meeting will 
be open to the public. Information about the ACCV and the agenda for 
this meeting can be obtained by accessing the following Web site: 
http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.

DATES: The meeting will be held on September 8, 2017, at 10:00 a.m. 
EDT.

ADDRESSES: The address for the meeting is 5600 Fishers Lane, Rockville, 
MD, Conference Room 5N54. The public can join the meeting by:
    1. (In Person) Persons interested in attending the meeting in 
person are encouraged to submit a written notification to: Annie 
Herzog, Division of Injury Compensation Programs (DICP), Healthcare 
Systems Bureau (HSB), HRSA, Rm. 8N146B, 5600 Fishers Lane, Rockville, 
Maryland 20857 or email: aherzog@hrsa.gov. Since this meeting is held 
in a federal government building, attendees will need to go through a 
security check to enter the building and participate in the meeting. 
This written notification is encouraged so that a list of attendees can 
be provided to make entry through security quicker. Persons may attend 
in person without providing written notification, but their entry into 
the building may be delayed due to security checks and the requirement 
to be escorted to the meeting by a federal government employee. To 
request an escort to the meeting after entering the building, call 
Amber Johnson at (301) 443-0129.
    2. (Audio Portion) Call the conference phone number (800) 369-1833 
and providing the following information:
    Leader Name: Dr. Narayan Nair
    Password: 6706374
    3. (Visual Portion) Connect to the ACCV Adobe Connect Pro Meeting 
using the following URL: https://hrsa.connectsolutions.com/accv/. 
Participants should call and connect 15 minutes prior to the meeting to 
allow time for the logistics to be set-up. If you have never attended 
an Adobe Connect meeting, please test your connection using the 
following URL: https://hrsa.connectsolutions.com/common/help/en/support/meeting_test.htm.
    Get a quick overview of the software at: http://www.adobe.com/go/connectpro_overview.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the ACCV should contact Annie Herzog, Program Analyst, DICP, 
HRSA in one of three ways: (1) Send a request to the following address: 
Annie Herzog, Program Analyst, DICP, HRSA, 5600 Fishers Lane, 8N146B, 
Rockville, Maryland 20857; (2) call (301) 443-6593; or (3) send an 
email to aherzog@hrsa.gov.
    The ACCV will meet on Friday, September 8, 2017, beginning at 10:00 
a.m. in the 5600 Fishers Lane Building, Rockville, Maryland 20857; 
however, meeting times and locations could change. For the latest 
information regarding meeting start time and location, please check the 
ACCV Web site: http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html.

SUPPLEMENTARY INFORMATION: The ACCV was established by section 2119 of 
the Public Health Service Act (the Act) (42 U.S.C. 300aa-19), as 
enacted by Public Law (Pub. L.) 99-660, and as subsequently amended, 
and advises the Secretary of HHS (the Secretary) on issues related to 
implementation of the National Vaccine Injury Compensation Program 
(VICP).
    Activities of the ACCV also include: Recommending changes to the 
Vaccine Injury Table on its own initiative or as the result of the 
filing of a petition; advising the Secretary in implementing section 
2127 of the Act regarding the need for childhood vaccination products 
that result in fewer or no significant adverse reactions; surveying 
federal, state, and local programs and activities related to gathering 
information on injuries associated with the administration of childhood 
vaccines, including the adverse reaction reporting requirements of 
section 2125(b) of the Act; advising the Secretary on the methods of 
obtaining, compiling, publishing, and using credible data related to 
the frequency and severity of adverse reactions associated with 
childhood vaccines; consulting on the development or revision of 
Vaccine Information Statements; and recommending to the Director of the 
National Vaccine Program research related to vaccine injuries which 
should be conducted to carry out the VICP.
    The agenda items for the meeting will include, but are not limited 
to, updates from DICP, Department of Justice, National Vaccine Program 
Office, Immunization Safety Office (Centers for Disease Control and 
Prevention), National Institute of Allergy and Infectious Diseases 
(National Institutes of Health) and Center for Biologics, Evaluation 
and Research (Food and Drug Administration). A draft agenda and 
additional meeting materials will be posted on the ACCV Web site 
(http://www.hrsa.gov/advisorycommittees/childhoodvaccines/index.html) 
prior to the meeting. Agenda items are subject to change as priorities 
dictate.
    Members of the public will have the opportunity to provide 
comments. Oral comments will be honored in the order they are requested 
and may be limited as time allows. Requests to make oral comments or 
provide written comments to the ACCV should be sent to Annie Herzog 
using the address and phone number above by September 4, 2017. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify Annie Herzog, using the address and phone number above at least 
10 days prior to the meeting.

Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2017-16582 Filed 8-4-17; 8:45 am]
 BILLING CODE 4165-15-P